Skip to content
Home/Companies/Healthcare/Phathom Pharmaceuticals
PP

Phathom Pharmaceuticals

Healthcare·US·Active·7yr hold

Phathom Pharmaceuticals is a healthcare company, headquartered in US.

Entry
2019
Hold
7yr
Status
Active
Est. EV
–

Who owns Phathom Pharmaceuticals?

Phathom Pharmaceuticals is currently owned by Abingworth through Abingworth Bioventures VII (2018 vintage), since 2019.

Hand-verified · updated 2026-06-10

Abingworth
Investor
Abingworth
Abingworth Bioventures VII · 2018 · Life Sciences VC

Key facts

HQUS
SectorHealthcare
StatusActive

More from Abingworth Bioventures VII

Other portfolio companies in the same fund.

Adicet Bio
Active
BiotechUS· 2021
Soteria Biotherapeutics
Active
HealthcareUS· 2021
Atsena Therapeutics
Active
BiotechUS· 2020
Orbus Therapeutics
Active
HealthcareUS· 2020
Q32 Bio
Active
BiotechUS· 2020
Scorpion Therapeutics
Active
BiotechUS· 2020

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
4ways
Active
ECI PartnersUK
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abcam (exited)
Active
EMV CapitalUK
Data refreshed weekly · Sourced from public filings